Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 4

1.

Altered microRNA expression in B lymphocytes in multiple sclerosis: towards a better understanding of treatment effects.

Sievers C, Meira M, Hoffmann F, Fontoura P, Kappos L, Lindberg RL.

Clin Immunol. 2012 Jul;144(1):70-9. doi: 10.1016/j.clim.2012.04.002. Epub 2012 May 2.

PMID:
22659298
2.

Natalizumab for relapsing-remitting multiple sclerosis.

Horga A, Tintoré M.

Neurologia. 2011 Jul-Aug;26(6):357-68. doi: 10.1016/j.nrl.2010.10.004. Epub 2010 Dec 28. Review. English, Spanish.

3.

MicroRNAs in multiple sclerosis and experimental autoimmune encephalomyelitis.

Thamilarasan M, Koczan D, Hecker M, Paap B, Zettl UK.

Autoimmun Rev. 2012 Jan;11(3):174-9. doi: 10.1016/j.autrev.2011.05.009. Epub 2011 May 18. Review.

PMID:
21621006
4.

Natalizumab (Tysabri) treatment for relapsing multiple sclerosis.

Johnson KP.

Neurologist. 2007 Jul;13(4):182-7. Review.

PMID:
17622909

Supplemental Content

Support Center